Zhejiang Haisen Pharmaceutical: Legal Opinions of Beijing Deheng (Hangzhou) Law Firm on the 2023 Annual General Meeting of Shareholders of Zhejiang Hisense Pharmaceutical Co., Ltd.
Zhejiang Haisen Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Zhejiang Haisen Pharmaceutical: Investor Relations Activity Record Form (Online Results Briefing for the First Quarter of 2023 and 2024)
Zhejiang Haisen Pharmaceutical: Investor Relations Activity Record Form 20240430
Zhejiang Haisen Pharmaceutical: Announcement on holding online results briefings for the 2023 and the first quarter of 2024
Hisense Pharmaceutical: CITIC Securities Co., Ltd.'s inspection results on Zhejiang Hisense Pharmaceutical Co., Ltd.'s 2023 continuous supervision work site inspection results and reminders to the company
Zhejiang Haisen Pharmaceutical: CITIC Securities Co., Ltd. report on the 2023 sponsorship work of Zhejiang Hisense Pharmaceutical Co., Ltd.
Zhejiang Haisen Pharmaceutical: CITIC Securities Co., Ltd. report on the 2023 continuous supervision and regular on-site inspection report of Zhejiang Hisense Pharmaceutical Co., Ltd.
Hisense Pharmaceuticals: First Quarter Report 2024
Hisense Pharmaceuticals: Announcement of Board Resolutions
Hisense Pharmaceutical: Announcement of Supervisory Board Resolutions
Hisense Pharmaceutical: Announcement of the 2024 Remuneration Plan for Directors, Supervisors and Senior Executives
Hisense Pharmaceutical: Annual Verification Report on the Use of Funds Raised
Hisense Pharmaceutical: 2023 Independent Director Debriefing Report (Dai Wentao)
Hisense Pharmaceuticals: Independent Director Work System
Hisense Pharmaceutical: Announcement of Supervisory Board Resolutions
Hisense Pharmaceuticals: 2023 Financial Results Report
Hisense Pharmaceutical: 2023 Independent Director Debriefing Report (Zheng Gang)
Hisense Pharmaceutical: Announcement on amending the “Articles of Association”
Hisense Pharmaceuticals: 2023 Annual Report on the Work of the Board
No Data